BioSpace News Archive

The International Society for Magnetic Resonance in Medicine is holding its Annual Meeting this week and will recognize several achievements with prestigious awards.

Life-saving initiative will provide pharmaceutical-grade medication as alternative to toxic illegal drug supply during COVID-19 pandemic and beyond

Advicenne (Euronext: ADVIC), a specialty pharmaceutical company dedicated to developing and commercializing innovative treatments for those suffering from rare renal diseases, announces US Food and Drug Administration (FDA) acceptance of the amended protocol of the Company’s US-based Phase III pivotal trial of ADV7103 (Sibnayal™) for the treatment of primary distal renal tubular acidosis (dRTA).

Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (Nasdaq: CTXR) today announced that Ilanit Allen has been appointed Vice President of Corporate Communications and Investor Relations, effective immediately.

BlueRock Therapeutics LP, a clinical stage biopharmaceutical company and wholly-owned subsidiary of Bayer AG, FUJIFILM Cellular Dynamics, Inc. a leading global developer and manufacturer of human induced pluripotent stem (iPS) cell technologies, and Opsis Therapeutics, LLC, a joint venture of FUJIFILM Cellular Dynamics (FCDI) and David Gamm, M.D., Ph.D., co-founder

The Medical Device Innovation Consortium announced a partnership with Booz Allen Hamilton to establish a benchmark of the medical device industry’s cybersecurity maturity and create resources to measure maturity over time.

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced its launch of the first available generic version, in the U.S., of THIOLA® (tiopronin) tablets, indicated, in combination with high fluid intake, alkali, and diet modification, for the prevention of cystine (kidney) stone formation in adults and pediatric patients 9 years of age and older with severe homozygous cystinuria

From coast to coast to coast, Canadians have been making extraordinary sacrifices to keep themselves, their families, and their communities safe from COVID-19.

Sincera Reproductive Medicine, formerly known as Abington Reproductive Medicine, announced that it has taken action after becoming aware of potential unauthorized access to certain patient information.

Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare a Canadian focused healthcare company with global reach and a diversified portfolio of commercial products, announced that at its 2021 Virtual Annual Meeting of Shareholders held on May 17, 2021, all nominees listed in the management proxy circular dated April 9, 2021 were elected as directors of the Company.